F13B Antibody Blocking Peptide(bs-1587P)-500ug

F13B Antibody Blocking Peptide

(bs-1587P)-500ug
收藏
  • ¥880
  • Bioss已认证
  • bs-1587P
  • 2025年10月16日
    avatar
    品牌商
    9钻石会员
  • 企业认证

    点击 QQ 联系

    • 详细信息
    • 技术资料
    • 规格

      500ug

    产品编号bs-1587P
    英文名称F13B Antibody Blocking Peptide
    中文名称凝血因子13(纤维蛋白稳定因子)封闭多肽
    英文别名coagulation factor XIII; F13A1; TGase; FXIIIA; F13A; Coagulation factor XIII A chain; Coagulation factor XIIIa; Protein-glutamine gamma-glutamyltransferase A chain; Transglutaminase A chain; coagulation factor XIII, A1 polypeptide; coagulation factor XIII A chain-like.
    纯化方法HPLC
    研究领域

    Cardiovascular > Blood > Coagulation > Common

    Cardiovascular > Blood > Serum Proteins

    亚基Tetramer of two A chains and two B chains.
    亚细胞定位Cytoplasm. Secreted. Note=Secreted into the blood plasma. Cytoplasmic in most tissues, but also secreted in the blood plasma. Tissue Specificity : The activation peptide is released by thrombin.
    组织特异性The activation peptide is released by thrombin.
    相似性Belongs to the transglutaminase superfamily. Transglutaminase family.
    功能Factor XIII is activated by thrombin and calcium ion to a transglutaminase that catalyzes the formation of gamma-glutamyl-epsilon-lysine cross-links between fibrin chains, thus stabilizing the fibrin clot. Also cross-link alpha-2-plasmin inhibitor, or fibronectin, to the alpha chains of fibrin.
    保存条件Shipped at 4℃. Stored at -20℃ for one year. Avoid repeated freeze/thaw cycles.
    注意事项This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications.
    背景资料This gene encodes the coagulation factor XIII A subunit. Coagulation factor XIII is the last zymogen to become activated in the blood coagulation cascade. Plasma factor XIII is a heterotetramer composed of 2 A subunits and 2 B subunits. The A subunits have catalytic function, and the B subunits do not have enzymatic activity and may serve as plasma carrier molecules. Platelet factor XIII is comprised only of 2 A subunits, which are identical to those of plasma origin. Upon cleavage of the activation peptide by thrombin and in the presence of calcium ion, the plasma factor XIII dissociates its B subunits and yields the same active enzyme, factor XIIIa, as platelet factor XIII. This enzyme acts as a transglutaminase to catalyze the formation of gamma-glutamyl-epsilon-lysine crosslinking between fibrin molecules, thus stabilizing the fibrin clot. It also crosslinks alpha-2-plasmin inhibitor, or fibronectin, to the alpha chains of fibrin. Factor XIII deficiency is classified into two categories: type I deficiency, characterized by the lack of both the A and B subunits; and type II deficiency, characterized by the lack of the A subunit alone. These defects can result in a lifelong bleeding tendency, defective wound healing, and habitual abortion.

     

     

    风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。

    图标技术资料

    暂无技术资料 索取技术资料

    同类产品报价

    产品名称
    产品价格
    公司名称
    报价日期
    ¥880
    北京博奥森生物技术有限公司
    2025年10月16日询价
    ¥1680
    武汉博欧特生物科技有限公司
    2025年05月18日询价
    ¥1759.50
    深圳欣博盛生物科技有限公司
    2025年07月16日询价
    ¥3784.50
    西宝生物科技(上海)股份有限公司
    2025年07月04日询价
    ¥1
    瑞博奥(广州)生物科技股份有限公司
    2025年07月11日询价
    F13B Antibody Blocking Peptide(bs-1587P)-500ug
    ¥880